title: Methylated DNA immunoprecipitation.
abstract: The identification of DNA methylation patterns is a common procedure in the study of epigenetics, as methylation is known to have significant effects on gene expression, and is involved with normal development as well as disease. Thus, the ability to discriminate between methylated DNA and non-methylated DNA is essential for generating methylation profiles for such studies. Methylated DNA immunoprecipitation (MeDIP) is an efficient technique for the extraction of methylated DNA from a sample of interest. A sample of as little as 200 ng of DNA is sufficient for the antibody, or immunoprecipitation (IP), reaction. DNA is sonicated into fragments ranging in size from 300-1000 bp, and is divided into immunoprecipitated (IP) and input (IN) portions. IP DNA is subsequently heat denatured and then incubated with anti-5'mC, allowing the monoclonal antibody to bind methylated DNA. After this, magnetic beads containing a secondary antibody with affinity for the primary antibody are added, and incubated. These bead-linked antibodies will bind the monoclonal antibody used in the first step. DNA bound to the antibody complex (methylated DNA) is separated from the rest of the DNA by using a magnet to pull the complexes out of solution. Several washes using IP buffer are then performed to remove the unbound, non-methylated DNA. The methylated DNA/antibody complexes are then digested with Proteinase K to digest the antibodies leaving only the methylated DNA intact. The enriched DNA is purified by phenol:chloroform extraction to remove the protein matter and then precipitated and resuspended in water for later use. PCR techniques can be used to validate the efficiency of the MeDIP procedure by analyzing the amplification products of IP and IN DNA for regions known to lack and known to contain methylated sequences. The purified methylated DNA can then be used for locus-specific (PCR) or genome-wide (microarray and sequencing) methylation studies, and is particularly useful when applied in conjunction with other research tools such as gene expression profiling and array comparative genome hybridization (CGH). Further investigation into DNA methylation will lead to the discovery of new epigenetic targets, which in turn, may be useful in developing new therapeutic or prognostic research tools for diseases such as cancer that are characterized by aberrantly methylated DNA.
authors.affiliation: Department of Cancer Genetics and Developmental Biology, BC Cancer Research Centre, Canada.
authors.forename: Kelsie L
authors.initials: KL
authors.lastname: Thu
authors.forename: Emily A
authors.initials: EA
authors.lastname: Vucic
authors.forename: Jennifer Y
authors.initials: JY
authors.lastname: Kennett
authors.forename: Cameron
authors.initials: C
authors.lastname: Heryet
authors.forename: Carolyn J
authors.initials: CJ
authors.lastname: Brown
authors.forename: Wan L
authors.initials: WL
authors.lastname: Lam
authors.forename: Ian M
authors.initials: IM
authors.lastname: Wilson
mesh_terms: D000818:Animals; D004247:DNA / Q000032:analysis* / Q000235:genetics / Q000302:isolation & purification; D019175:DNA Methylation; D006801:Humans; D047468:Immunoprecipitation / Q000379:methods*; D016133:Polymerase Chain Reaction / Q000379:methods
chemical_list: D004247:DNA